Vericel Corp Ord Stock Price To Sales
| VCEL Stock | USD 59.11 2.40 4.23% |
Vericel Corp Ord fundamentals help investors to digest information that contributes to Vericel Corp's financial success or failures. It also enables traders to predict the movement of Vericel Stock. The fundamental analysis module provides a way to measure Vericel Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vericel Corp stock.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 8.58 | 8.15 |
Vericel | Price To Sales |
Vericel Corp Ord Company Price To Sales Analysis
Vericel Corp's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Vericel Corp Price To Sales | 12.86 X |
Most of Vericel Corp's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vericel Corp Ord is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Vericel Price To Sales Driver Correlations
Understanding the fundamental principles of building solid financial models for Vericel Corp is extremely important. It helps to project a fair market value of Vericel Stock properly, considering its historical fundamentals such as Price To Sales. Since Vericel Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Vericel Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Vericel Corp's interrelated accounts and indicators.
Click cells to compare fundamentals
Vericel Price To Sales Historical Pattern
Today, most investors in Vericel Corp Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Vericel Corp's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Vericel Corp price to sales as a starting point in their analysis.
Vericel Corp Price To Sales |
| Timeline |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Vericel Price To Sales Ratio
Price To Sales Ratio |
|
Based on the latest financial disclosure, Vericel Corp Ord has a Price To Sales of 12.8616 times. This is 39.9% lower than that of the Biotechnology sector and 86.93% lower than that of the Health Care industry. The price to sales for all United States stocks is 12.62% lower than that of the firm.
Vericel Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vericel Corp's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vericel Corp could also be used in its relative valuation, which is a method of valuing Vericel Corp by comparing valuation metrics of similar companies.Vericel Corp is currently under evaluation in price to sales category among its peers.
Vericel Corp ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Vericel Corp's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Vericel Corp's managers, analysts, and investors.Environmental | Governance | Social |
Vericel Fundamentals
| Return On Equity | 0.0154 | ||||
| Return On Asset | -0.0022 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | (0.04) % | ||||
| Current Valuation | 2.91 B | ||||
| Shares Outstanding | 49.36 M | ||||
| Shares Owned By Insiders | 0.92 % | ||||
| Shares Owned By Institutions | 99.08 % | ||||
| Number Of Shares Shorted | 4.17 M | ||||
| Price To Earning | 357.33 X | ||||
| Price To Book | 11.33 X | ||||
| Price To Sales | 12.86 X | ||||
| Revenue | 197.52 M | ||||
| Gross Profit | 109.79 M | ||||
| EBITDA | 2.86 M | ||||
| Net Income | (3.18 M) | ||||
| Cash And Equivalents | 100.69 M | ||||
| Cash Per Share | 2.13 X | ||||
| Total Debt | 88.14 M | ||||
| Debt To Equity | 0.28 % | ||||
| Current Ratio | 6.20 X | ||||
| Book Value Per Share | 5.23 X | ||||
| Cash Flow From Operations | 35.31 M | ||||
| Short Ratio | 12.44 X | ||||
| Earnings Per Share | 0.08 X | ||||
| Target Price | 59.38 | ||||
| Number Of Employees | 314 | ||||
| Beta | 1.67 | ||||
| Market Capitalization | 2.92 B | ||||
| Total Asset | 353.66 M | ||||
| Retained Earnings | (403.18 M) | ||||
| Working Capital | 159.88 M | ||||
| Current Asset | 21.1 M | ||||
| Current Liabilities | 15.36 M | ||||
| Net Asset | 353.66 M |
About Vericel Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vericel Corp Ord's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vericel Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vericel Corp Ord based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Vericel Corp Piotroski F Score and Vericel Corp Altman Z Score analysis. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.045 | Earnings Share 0.08 | Revenue Per Share 4.685 | Quarterly Revenue Growth 0.27 | Return On Assets (0) |
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.